三维超声血管壁厚度图评估疗法对颈动脉粥样硬化的影响
本研究提出一种通过测量颈动脉血管壁加斑块厚度变化加权平均值来评估疗法对粥样硬化影响的新方法,在120例随机分配至石榴汁/提取物组或安慰剂组的患者中,于基线和一年后采集三维超声图像,重建三维血管壁厚度图并投影至颈动脉模板获得二维图,经解剖对应优化后计算加权平均值。采用对应配准的二维血管壁厚度图测得的加权平均厚度变化在石榴汁组与安慰剂组之间检测到显著差异(P=0.008)。该方法可提高涉及动脉粥样硬化新疗法的概念验证研究的成本效益。
要点
- 三维超声血管壁厚度图可投影为二维图并计算加权平均厚度变化。
- 对应配准后的加权平均厚度变化检测到石榴汁组与安慰剂组差异显著(P=0.008)。
- 该方法旨在提高动脉粥样硬化新疗法概念验证研究的成本效益。
核心结论
- 采用对应配准的二维血管壁厚度图测得的加权平均血管壁加斑块厚度变化(ΔVWT¯Weighted,MDL)在石榴汁/提取物组与安慰剂组之间检测到显著差异(P=0.008),该方法可提高动脉粥样硬化新疗法概念验证研究的成本效益。
研究设计与样本
- 研究纳入120例随机分配至石榴汁/提取物组或安慰剂组的患者,于基线和一年后采集颈动脉三维超声图像,重建三维血管壁厚度图并投影至颈动脉模板获得二维血管壁厚度图,经解剖对应优化后计算每位受试者的加权平均厚度变化。
诊断标准与关键数值
- 从经对应配准的二维血管壁厚度图测得的加权平均血管壁加斑块厚度变化(ΔVWT¯Weighted,MDL)在石榴汁/提取物组与安慰剂组之间差异显著(P=0.008)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
We present a new method for assessing the effects of therapies on atherosclerosis, by measuring the weighted average of carotid vessel-wall-plus-plaque thickness change (ΔVWT¯Weighted) in 120 patients randomized to pomegranate juice/extract versus placebo. Three-dimensional ultrasound images were acquired at baseline and one year after. Three-dimensional VWT maps were reconstructed and then projected onto a carotid template to obtain two-dimensional VWT maps. Anatomic correspondence on the two-dimensional VWT maps was optimized to reduce misalignment for the same subject and across subjects. A weight was computed at each point on the two-dimensional VWT map to highlight anatomic locations likely to exhibit plaque progression/regression, resulting in ΔVWT¯Weighted for each subject. The weighted average of VWT-Change measured from the two-dimensional VWT maps with correspondence alignment (ΔVWT¯Weighted,MDL) detected a significant difference between the pomegranate and placebo groups (P = 0.008). This method improves the cost-effectiveness of proof-of-concept studies involving new therapies for atherosclerosis.
引用
- Zhao Y, Spence JD, Chiu B, et al. Three-dimensional ultrasound assessment of effects of therapies on carotid atherosclerosis using vessel wall thickness maps. Ultrasound Med Biol. 2021. PMID: 34148714. doi:10.1016/j.ultrasmedbio.2021.04.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。